These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37227180)

  • 1. Novel concepts of treating vascular inflammation underlying neonatal lung diseases.
    Sehgal A; Garrick SP; Nold MF; Nold-Petry CA
    J Appl Physiol (1985); 2023 Jul; 135(1):174-182. PubMed ID: 37227180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchopulmonary dysplasia: Pathophysiology and potential anti-inflammatory therapies.
    Papagianis PC; Pillow JJ; Moss TJ
    Paediatr Respir Rev; 2019 Apr; 30():34-41. PubMed ID: 30201135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal growth restriction and neonatal-pediatric lung diseases: Vascular mechanistic links and therapeutic directions.
    Sehgal A; Dassios T; Nold MF; Nold-Petry CA; Greenough A
    Paediatr Respir Rev; 2022 Dec; 44():19-30. PubMed ID: 36503648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of the Interleukin-1 Family in Complications of Prematurity.
    Green EA; Garrick SP; Peterson B; Berger PJ; Galinsky R; Hunt RW; Cho SX; Bourke JE; Nold MF; Nold-Petry CA
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW; Cheong JL; Ehrenkranz RA; Halliday HL
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001146. PubMed ID: 29063585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticosteroids in the prevention and treatment of infants with bronchopulmonary dysplasia: Part I. systemic corticosteroids.
    Szabó H; Baraldi E; Colin AA
    Pediatr Pulmonol; 2022 Mar; 57(3):600-608. PubMed ID: 34964559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW; Cheong JL; Ehrenkranz RA; Halliday HL
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001145. PubMed ID: 29063594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
    Onland W; Offringa M; van Kaam A
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD002311. PubMed ID: 28836266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
    Onland W; Offringa M; van Kaam A
    Cochrane Database Syst Rev; 2012 Apr; (4):CD002311. PubMed ID: 22513906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postnatal steroids as lung protective and anti-inflammatory in preterm lambs exposed to antenatal inflammation.
    Papagianis PC; Noble PB; Ahmadi-Noorbakhsh S; Savigni D; Moss TJM; Pillow JJ
    Pediatr Res; 2024 Mar; 95(4):931-940. PubMed ID: 38066248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Glucocorticoide therapy in premature infants: French practices in 2006].
    Autret-Leca E; Bauer S; Alberti C; Jonville-Béra AP; Aujard Y; Bensouda-Grimaldi L; Baud O
    Arch Pediatr; 2009 Jul; 16(7):999-1004. PubMed ID: 19410441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [From classic to new bronchopulmonary dysplasia].
    Kramer BW; Lievense S; Been JV; Zimmermann LJ
    Ned Tijdschr Geneeskd; 2010; 154():A1024. PubMed ID: 20456770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA; Doyle LW
    Cochrane Database Syst Rev; 2010 Jan; (1):CD001146. PubMed ID: 20091516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchopulmonary dysplasia in preterm infants: pathophysiology and management strategies.
    D'Angio CT; Maniscalco WM
    Paediatr Drugs; 2004; 6(5):303-30. PubMed ID: 15449969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postnatal steroid management in preterm infants with evolving bronchopulmonary dysplasia.
    Htun ZT; Schulz EV; Desai RK; Marasch JL; McPherson CC; Mastrandrea LD; Jobe AH; Ryan RM
    J Perinatol; 2021 Aug; 41(8):1783-1796. PubMed ID: 34012057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory burst activity in bronchopulmonary dysplasia and changes with dexamethasone.
    Ballabh P; Simm M; Kumari J; Califano C; Aghai Z; Laborada G; Sison C; Cunningham-Rundles S
    Pediatr Pulmonol; 2003 May; 35(5):392-9. PubMed ID: 12687597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone treatment after the first week of life for bronchopulmonary dysplasia in preterm infants: a systematic review.
    Doyle LW; Ehrenkranz RA; Halliday HL
    Neonatology; 2010; 98(4):289-96. PubMed ID: 20453523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1 receptor antagonist prevents murine bronchopulmonary dysplasia induced by perinatal inflammation and hyperoxia.
    Nold MF; Mangan NE; Rudloff I; Cho SX; Shariatian N; Samarasinghe TD; Skuza EM; Pedersen J; Veldman A; Berger PJ; Nold-Petry CA
    Proc Natl Acad Sci U S A; 2013 Aug; 110(35):14384-9. PubMed ID: 23946428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Concepts of Corticosteroids Use for the Prevention of Bronchopulmonary Dysplasia.
    Perrone S; Orlando S; Petrolini C; Marinelli F; Moretti S; Corradi M; Giordano M; De Bernardo G
    Curr Pediatr Rev; 2023; 19(3):276-284. PubMed ID: 36043724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.